Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

The people's Hospital of Chizhou, Chizhou